Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in Stable Vitiligo
NCT01202513Phase 4Withdrawn
- Sponsor
- Gian Sagar Medical College and Hospital
- Start
- Aug 2010
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, single-blind, single-arm trial of bimatoprost in Vitiligo, sponsored by Gian Sagar Medical College and Hospital. Primary endpoint: Percentage of repigmentation at 4 months. Planned start Aug 2010; status: withdrawn.
02
Drugs
bimatoprost
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT01202513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202513.